Academic Journal
View in EDS

Evaluation of Maternal Serum sHLA-G Levels for Trisomy 18 Fetuses Screening at Second Trimester

Bibliographic Details
Title: Evaluation of Maternal Serum sHLA-G Levels for Trisomy 18 Fetuses Screening at Second Trimester
Authors: Danping Xu, Yiyang Zhu, Lanfang Li, Yingping Xu, Weihua Yan, Meizhen Dai, Linghong Gan
Source: Frontiers in Genetics, Vol 11 (2021)
Publisher Information: Frontiers Media S.A., 2021.
Publication Year: 2021
Collection: LCC:Genetics
Subject Terms: human leukocyte antigen-G, soluble HLA-G, pregnancy, fetus, chromsome, trisomy, Genetics, QH426-470
More Details: Human leukocyte antigen-G (HLA-G) has been widely acknowledged to play critical roles in fetal-maternal maintenance. However, the significance of using maternal serum sHLA-G to detect prenatal chromosomal abnormality has not been investigated. In China, prenatal screening using maternal α-fetoprotein (AFP), unconjugated estriol (uE3), and free β subunit human chorionic gonadotropin (β-hCG) in the second trimester has been widely applied. In this study, we evaluated the use of sHLA-G as a screening marker, compared with traditional second trimester prenatal screening. Serum samples from 1,019 singleton women in their second trimester were assessed. Among them, 139 infants were confirmed with trisomy 21 (T21) by karyotyping, 83 were confirmed with trisomy 18 (T18), and the remaining 797 infants had no abnormalities. The sHLA-G levels in maternal sera were significantly lower in pregnant women with T18 fetuses (median: 47.8 U/ml, range: 9.8–234.2 U/ml) and significantly higher in those with T21 fetuses (median: 125.7 U/ml, range: 28.7–831.7 U/ml), compared with the normal controls (median: 106.3 U/ml, range: 50.5–1136.4 U/ml) (p < 0.001). The risk values of the screening of T21 or T18 fetuses were assessed using mean and standard deviation log10 analyte multiples of median (MoM) which showed that the predictive values of sHLA-G were the same as free β-hCG, and superior to AFP and uE3 for T18 screening. Logistic regression analysis revealed that sHLA-G MoM was the highest risk factor associated with pregnant women carrying T18 fetuses [Exp(B): 171.26, 95% CI: 36.30–807.97, p < 0.001]. Receiver operating characteristic (ROC) analysis revealed that the area under ROC curve for sHLA-G MoM was 0.915 (95% CI, 0.871–0.959, p < 0.001), for AFP MoM was 0.796 (95% CI, 0.730–0.861, p < 0.001), for free β-hCG MoM was 0.881 (95% CI, 0.829–0.934, p < 0.001), and for uE3 MoM was 0.876 (95% CI, 0.828–0.923, p < 0.001) in the T18 group. sHLA-G MoM demonstrated the best sensitivity and negative predictive value. For the first time, our findings reveal that sHLA-G is a better second trimester screening marker for the detection of T18 fetuses and the combined application of sHLA-G with AFP, free β-hCG, and uE3 could improve clinical screening for T18 fetuses.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 1664-8021
Relation: https://www.frontiersin.org/articles/10.3389/fgene.2020.497264/full; https://doaj.org/toc/1664-8021
DOI: 10.3389/fgene.2020.497264
Access URL: https://doaj.org/article/c5c5eea4f9cc499da62c7dca01ea748b
Accession Number: edsdoj.5c5eea4f9cc499da62c7dca01ea748b
Database: Directory of Open Access Journals
FullText Text:
  Availability: 0
CustomLinks:
  – Url: https://resolver.ebsco.com/c/xy5jbn/result?sid=EBSCO:edsdoj&genre=article&issn=16648021&ISBN=&volume=11&issue=&date=20210101&spage=&pages=&title=Frontiers in Genetics&atitle=Evaluation%20of%20Maternal%20Serum%20sHLA-G%20Levels%20for%20Trisomy%2018%20Fetuses%20Screening%20at%20Second%20Trimester&aulast=Danping%20Xu&id=DOI:10.3389/fgene.2020.497264
    Name: Full Text Finder (for New FTF UI) (s8985755)
    Category: fullText
    Text: Find It @ SCU Libraries
    MouseOverText: Find It @ SCU Libraries
  – Url: https://doaj.org/article/c5c5eea4f9cc499da62c7dca01ea748b
    Name: EDS - DOAJ (s8985755)
    Category: fullText
    Text: View record from DOAJ
    MouseOverText: View record from DOAJ
Header DbId: edsdoj
DbLabel: Directory of Open Access Journals
An: edsdoj.5c5eea4f9cc499da62c7dca01ea748b
RelevancyScore: 919
AccessLevel: 3
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 918.9462890625
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Evaluation of Maternal Serum sHLA-G Levels for Trisomy 18 Fetuses Screening at Second Trimester
– Name: Author
  Label: Authors
  Group: Au
  Data: &lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Danping+Xu%22&quot;&gt;Danping Xu&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Yiyang+Zhu%22&quot;&gt;Yiyang Zhu&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Lanfang+Li%22&quot;&gt;Lanfang Li&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Yingping+Xu%22&quot;&gt;Yingping Xu&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Weihua+Yan%22&quot;&gt;Weihua Yan&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Meizhen+Dai%22&quot;&gt;Meizhen Dai&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Linghong+Gan%22&quot;&gt;Linghong Gan&lt;/searchLink&gt;
– Name: TitleSource
  Label: Source
  Group: Src
  Data: Frontiers in Genetics, Vol 11 (2021)
– Name: Publisher
  Label: Publisher Information
  Group: PubInfo
  Data: Frontiers Media S.A., 2021.
– Name: DatePubCY
  Label: Publication Year
  Group: Date
  Data: 2021
– Name: Subset
  Label: Collection
  Group: HoldingsInfo
  Data: LCC:Genetics
– Name: Subject
  Label: Subject Terms
  Group: Su
  Data: &lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22human+leukocyte+antigen-G%22&quot;&gt;human leukocyte antigen-G&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22soluble+HLA-G%22&quot;&gt;soluble HLA-G&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22pregnancy%22&quot;&gt;pregnancy&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22fetus%22&quot;&gt;fetus&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22chromsome%22&quot;&gt;chromsome&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22trisomy%22&quot;&gt;trisomy&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Genetics%22&quot;&gt;Genetics&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22QH426-470%22&quot;&gt;QH426-470&lt;/searchLink&gt;
– Name: Abstract
  Label: Description
  Group: Ab
  Data: Human leukocyte antigen-G (HLA-G) has been widely acknowledged to play critical roles in fetal-maternal maintenance. However, the significance of using maternal serum sHLA-G to detect prenatal chromosomal abnormality has not been investigated. In China, prenatal screening using maternal α-fetoprotein (AFP), unconjugated estriol (uE3), and free β subunit human chorionic gonadotropin (β-hCG) in the second trimester has been widely applied. In this study, we evaluated the use of sHLA-G as a screening marker, compared with traditional second trimester prenatal screening. Serum samples from 1,019 singleton women in their second trimester were assessed. Among them, 139 infants were confirmed with trisomy 21 (T21) by karyotyping, 83 were confirmed with trisomy 18 (T18), and the remaining 797 infants had no abnormalities. The sHLA-G levels in maternal sera were significantly lower in pregnant women with T18 fetuses (median: 47.8 U/ml, range: 9.8–234.2 U/ml) and significantly higher in those with T21 fetuses (median: 125.7 U/ml, range: 28.7–831.7 U/ml), compared with the normal controls (median: 106.3 U/ml, range: 50.5–1136.4 U/ml) (p &lt; 0.001). The risk values of the screening of T21 or T18 fetuses were assessed using mean and standard deviation log10 analyte multiples of median (MoM) which showed that the predictive values of sHLA-G were the same as free β-hCG, and superior to AFP and uE3 for T18 screening. Logistic regression analysis revealed that sHLA-G MoM was the highest risk factor associated with pregnant women carrying T18 fetuses [Exp(B): 171.26, 95% CI: 36.30–807.97, p &lt; 0.001]. Receiver operating characteristic (ROC) analysis revealed that the area under ROC curve for sHLA-G MoM was 0.915 (95% CI, 0.871–0.959, p &lt; 0.001), for AFP MoM was 0.796 (95% CI, 0.730–0.861, p &lt; 0.001), for free β-hCG MoM was 0.881 (95% CI, 0.829–0.934, p &lt; 0.001), and for uE3 MoM was 0.876 (95% CI, 0.828–0.923, p &lt; 0.001) in the T18 group. sHLA-G MoM demonstrated the best sensitivity and negative predictive value. For the first time, our findings reveal that sHLA-G is a better second trimester screening marker for the detection of T18 fetuses and the combined application of sHLA-G with AFP, free β-hCG, and uE3 could improve clinical screening for T18 fetuses.
– Name: TypeDocument
  Label: Document Type
  Group: TypDoc
  Data: article
– Name: Format
  Label: File Description
  Group: SrcInfo
  Data: electronic resource
– Name: Language
  Label: Language
  Group: Lang
  Data: English
– Name: ISSN
  Label: ISSN
  Group: ISSN
  Data: 1664-8021
– Name: NoteTitleSource
  Label: Relation
  Group: SrcInfo
  Data: https://www.frontiersin.org/articles/10.3389/fgene.2020.497264/full; https://doaj.org/toc/1664-8021
– Name: DOI
  Label: DOI
  Group: ID
  Data: 10.3389/fgene.2020.497264
– Name: URL
  Label: Access URL
  Group: URL
  Data: &lt;link linkTarget=&quot;URL&quot; linkTerm=&quot;https://doaj.org/article/c5c5eea4f9cc499da62c7dca01ea748b&quot; linkWindow=&quot;_blank&quot;&gt;https://doaj.org/article/c5c5eea4f9cc499da62c7dca01ea748b&lt;/link&gt;
– Name: AN
  Label: Accession Number
  Group: ID
  Data: edsdoj.5c5eea4f9cc499da62c7dca01ea748b
PLink https://login.libproxy.scu.edu/login?url=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.5c5eea4f9cc499da62c7dca01ea748b
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fgene.2020.497264
    Languages:
      – Text: English
    Subjects:
      – SubjectFull: human leukocyte antigen-G
        Type: general
      – SubjectFull: soluble HLA-G
        Type: general
      – SubjectFull: pregnancy
        Type: general
      – SubjectFull: fetus
        Type: general
      – SubjectFull: chromsome
        Type: general
      – SubjectFull: trisomy
        Type: general
      – SubjectFull: Genetics
        Type: general
      – SubjectFull: QH426-470
        Type: general
    Titles:
      – TitleFull: Evaluation of Maternal Serum sHLA-G Levels for Trisomy 18 Fetuses Screening at Second Trimester
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Danping Xu
      – PersonEntity:
          Name:
            NameFull: Yiyang Zhu
      – PersonEntity:
          Name:
            NameFull: Lanfang Li
      – PersonEntity:
          Name:
            NameFull: Yingping Xu
      – PersonEntity:
          Name:
            NameFull: Weihua Yan
      – PersonEntity:
          Name:
            NameFull: Meizhen Dai
      – PersonEntity:
          Name:
            NameFull: Linghong Gan
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-print
              Value: 16648021
          Numbering:
            – Type: volume
              Value: 11
          Titles:
            – TitleFull: Frontiers in Genetics
              Type: main
ResultId 1